Please use this identifier to cite or link to this item: https://scidar.kg.ac.rs/handle/123456789/8715
Full metadata record
DC FieldValueLanguage
dc.rights.licenseopenAccess-
dc.contributor.authorSimonovic N.-
dc.contributor.authorJeremic, Jovana-
dc.date.accessioned2020-09-19T16:30:21Z-
dc.date.available2020-09-19T16:30:21Z-
dc.date.issued2017-
dc.identifier.issn1820-8665-
dc.identifier.urihttps://scidar.kg.ac.rs/handle/123456789/8715-
dc.description.abstract© 2017, University of Kragujevac, Faculty of Science. All rights reserved. Coronary heart disease is the leading cause of mortality and morbidity worldwide. The effects of coronary heart disease are usually attributable to the detrimental effects of acute myocardial ischaemia-reperfusion injury. Newer strategies such as ischaemic or pharmacological preconditioning have been shown to condition the myocardium to ischaemiareperfusion injury and thus reduce the final infarct size. This review investigates the role of calcium channel blockers in myocardial preconditioning. Additionally, special attention is given to nicorandil whose mechanism of action may be associated with the cardioprotective effects of preconditioning. There are still many uncertainties in understanding the role of these agents in preconditioning, but future research in this direction will certainly help reduce coronary heart disease.-
dc.rightsinfo:eu-repo/semantics/openAccess-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/-
dc.sourceSerbian Journal of Experimental and Clinical Research-
dc.titleRole of calcium channel blockers in myocardial preconditioning-
dc.typereview-
dc.identifier.doi10.1515/SJECR-2016-0073-
dc.identifier.scopus2-s2.0-85044137573-
Appears in Collections:Faculty of Medical Sciences, Kragujevac

Page views(s)

507

Downloads(s)

16

Files in This Item:
File Description SizeFormat 
10.1515-SJECR-2016-0073.pdf542.37 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons